CircBioCare | Circulating epigenetic and protein biomarkers for early OA care

The project aims to improve outcomes by reducing pain, preserving joint function and enhancing quality of life. Addressing OA early can also lower healthcare costs by preventing expensive treatments like joint replacement surgery. Additionally, identifying molecular markers will uncover new insights into OA’s mechanisms, paving the way for innovative treatments.

CircBioCare revolutionizes early knee OA diagnosis by leveraging novel miRNA and protein biomarkers from serum, enabling precise patient stratification for personalized treatment. By correlating local and systemic markers and exploring IPFP’s role in biomarker secretion, we pave the way for innovative, targeted therapies.

Our partners play a key role. Through collaboration, we combine expertise in biomarker research, patient stratification, and innovative healthcare solutions to drive personalized treatments. Meet the team shaping the future of osteoarthritis care!

Explore our scientific contributions advancing early knee OA diagnosis. Our research is changing the way we diagnose and understand osteoarthritis.